Vigil Neuroscience, Inc. (VIGL) Description, Stock price, News & Info.

#ThinkSabio Latest News

Vigil Neuroscience Reports Positive Data from its Phase 1 Clinical Trial Evaluating VG-3927 for the Potential Treatment of Alzheimer’s Disease